A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults.
Texto
Documentos relacionados
Tribulus terrestris for treatment of sexual dysfunction in women: randomized double-blind placebo - controlled study. Androgens and the ageing male
Na concepção do programa considerou-se que a informação a enviar para o robot era a seguinte: ins- trução, duração da instrução; a próxima posição da instrução, dependendo
To examine the effects of HIV-1 Nef expression on viral replication and transmission in a physiologically relevant system, HIV-1 infection of activated PBLs and DC-mediated
responses against Gag GW9 and Nef RM9 antigens in a conventional (18 h) and an extended IFN- c ELISPOT assay. Due to limited numbers of cells per sample and limited resources
A multicenter, randomized, double-blind, placebo-controlled study of eficacy and safety of 3 doses of botulinum toxin A in the treatment of glabellar lines.. Rzany
This was a randomized, double-blind, placebo-controlled study, with the aim of evaluating the eficacy and safety of cumaru syrup as complementary therapy in mild persistent
This double-blind, randomized, placebo-controlled clinical trial is the irst study to evaluate the toxicology and safety of tincture of O. alata in patients with
As both cytokines are prominent representatives of type 2 inflammatory reactions, we performed a double-blind, placebo-controlled randomized study on the effectiveness and safety